Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Evaluate the Role of Anthracycline After Radio Therapy in Patients With Glioblastoma (pGBM).
- First Posted Date
- 2024-03-07
- Last Posted Date
- 2024-03-07
- Lead Sponsor
- Iacopo Sardi
- Target Recruit Count
- 20
- Registration Number
- NCT06297512
- Locations
- 🇮🇹
Meyer Children's Hospital IRCCS, Florence, Italy
News
No news found